Terms: = Liver cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Diagnosis
52 results:
1. Molecular pathological approach to cancer epigenomics and its clinical application.
Kanai Y
Pathol Int; 2024 Apr; 74(4):167-186. PubMed ID: 38482965
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of CT and gadoxetic acid-enhanced MRI with liver imaging reporting and data system to assess liver tumors before resection.
Chen MF; Ho MC; Kao JH; Hwang RM; Deng SB; Yen KC; Liang PC; Wu CH
J Formos Med Assoc; 2024 Mar; 123(3):318-324. PubMed ID: 38044205
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid-enhanced MRI.
Huang P; Wu F; Hou K; Zhou C; Xiao Y; Wang C; Miao G; Yang C; Zeng M
Eur Radiol; 2024 Apr; 34(4):2271-2282. PubMed ID: 37792079
[TBL] [Abstract] [Full Text] [Related]
4. LI-RADS threshold growth based on tumor growth rate can improve the diagnosis of hepatocellular carcinoma ≤ 3.0 cm.
Jeong B; Choi SJ; Choi SH; Jang HJ; Byun JH; Won HJ; Shin YM
Eur Radiol; 2024 Feb; 34(2):1210-1218. PubMed ID: 37589898
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of washout using subtraction MRI for the diagnosis of hepatocellular carcinoma in cirrhotic patients with spontaneously T1-hyperintense nodules.
Bizeul J; Ronot M; Roux M; Cannella R; Lebigot J; Aubé C; Paisant A
Diagn Interv Imaging; 2023 Sep; 104(9):427-434. PubMed ID: 37120391
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic Performance of the 2018 EASL vs. LI-RADS for Hepatocellular Carcinoma Using CT and MRI: A Systematic Review and Meta-Analysis of Comparative Studies.
Shin J; Lee S; Yoon JK; Roh YH
J Magn Reson Imaging; 2023 Dec; 58(6):1942-1950. PubMed ID: 37010244
[TBL] [Abstract] [Full Text] [Related]
7. Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive diagnosis of Hepatocellular Carcinoma Using the Korean liver cancer Association-National cancer Center 2022 Criteria.
Yoon JK; Han DH; Lee S; Choi JY; Choi GH; Kim DY; Kim MJ
Cancer Res Treat; 2023 Jul; 55(3):939-947. PubMed ID: 36791769
[TBL] [Abstract] [Full Text] [Related]
8. An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on gadoxetic acid-enhanced MRI.
Huang P; Zhou C; Wu F; Xiao Y; Qian X; Wang Y; Yang C; Zeng M
Eur Radiol; 2023 Apr; 33(4):2735-2745. PubMed ID: 36472696
[TBL] [Abstract] [Full Text] [Related]
9. A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy.
Kim SH; Park J; Park WS; Hong D; Chung J
Investig Clin Urol; 2022 Nov; 63(6):602-611. PubMed ID: 36347549
[TBL] [Abstract] [Full Text] [Related]
10. Multiple arterial-phase MRI with gadoxetic acid improves diagnosis of hepatocellular carcinoma ≤3.0 cm.
Hong SB; Hong S; Choi SH; Park SY; Shim JH; Kim SY; Lee SS; Kim S
Liver Int; 2023 Feb; 43(2):462-470. PubMed ID: 36317670
[TBL] [Abstract] [Full Text] [Related]
11. Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies.
Illiano M; Colinard M; Taque S; Mallon B; Larue C; Laithier V; Vérité-Goulard C; Sudour-Bonnange H; Faure-Conter C; Coze C; Aerts I; De Maricourt CD; Paillard C; Branchereau S; Brugières L; Fresneau B
Hepatol Int; 2022 Feb; 16(1):125-134. PubMed ID: 34506008
[TBL] [Abstract] [Full Text] [Related]
12. Treatment challenges and health conditions among people living with HIV with or without substance use disorder in the Russian Federation.
Kuznetsov S; Eremin A; Zaytseva E; Young B; Basova A; Paice A; Marin O; de Los Rios P; Okoli C
AIDS Care; 2022 Oct; 34(10):1276-1281. PubMed ID: 34369217
[TBL] [Abstract] [Full Text] [Related]
13. Should Threshold Growth Be Considered a Major Feature in the diagnosis of Hepatocellular Carcinoma Using LI-RADS?
Park JH; Chung YE; Seo N; Choi JY; Park MS; Kim MJ
Korean J Radiol; 2021 Oct; 22(10):1628-1639. PubMed ID: 34269533
[TBL] [Abstract] [Full Text] [Related]
14. Intraindividual Comparison of Hepatocellular Carcinoma Washout between MRIs with Hepatobiliary and Extracellular Contrast Agents.
Kim YY; Kim YK; Min JH; Cha DI; Kim JM; Choi GS; Ahn S
Korean J Radiol; 2021 May; 22(5):725-734. PubMed ID: 33660458
[TBL] [Abstract] [Full Text] [Related]
15. Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK.
Sharpley FA; Manwani R; Petrie A; Mahmood S; Sachchithanantham S; Lachmann HJ; Martinez De Azcona Naharro A; Gillmore JD; Whelan CJ; Fontana M; Cohen O; Hawkins PN; Wechalekar AD
Eur J Haematol; 2021 Apr; 106(4):537-545. PubMed ID: 33460466
[TBL] [Abstract] [Full Text] [Related]
16. Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium-enhanced MRI.
Kim SS; Lee S; Bae H; Chung YE; Choi JY; Park MS; Kim MJ
Eur Radiol; 2021 Mar; 31(3):1620-1629. PubMed ID: 32886205
[TBL] [Abstract] [Full Text] [Related]
17. Application of liver Imaging Reporting and Data System version 2018 ancillary features to upgrade from LR-4 to LR-5 on gadoxetic acid-enhanced MRI.
Lee S; Kim SS; Bae H; Shin J; Yoon JK; Kim MJ
Eur Radiol; 2021 Feb; 31(2):855-863. PubMed ID: 32809162
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.
Lee S; Kim SS; Chang DR; Kim H; Kim MJ
Clin Mol Hepatol; 2020 Jul; 26(3):340-351. PubMed ID: 32492765
[TBL] [Abstract] [Full Text] [Related]
19. Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B.
Yip TC; Wong VW; Chan HL; Tse YK; Hui VW; Liang LY; Lee HW; Lui GC; Kong AP; Wong GL
J Viral Hepat; 2020 Sep; 27(9):904-914. PubMed ID: 32340077
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of hepatic epithelioid angiomyolipoma and non-hepatitis B, non-hepatitis C hepatocellular carcinoma on contrast-enhanced ultrasound.
Tan Y; Xie XY; Li XJ; Liu DH; Zhou LY; Zhang XE; Lin Y; Wang W; Wu SS; Liu J; Huang GL
Diagn Interv Imaging; 2020 Nov; 101(11):733-738. PubMed ID: 32331793
[TBL] [Abstract] [Full Text] [Related]
[Next]
